Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Part D Cost Sharing Cap May Have Broadest Benefit For Jakafi, Revlimid, Pomalyst, Imbruvica Users
Sep 14 2021
•
By
Cathy Kelly
Legislation Establishing Part D Cap Under Consideration In US Congress • Source: Alamy
More from Medicare
More from Government Payers